Global Lung Cancer Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 124 pages | ID: GAFF9D9123DGEN
GlobalInfoResearch

Abstracts

Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.

SCOPE OF THE REPORT:

As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
The global Lung Cancer Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lung Cancer Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Lung Cancer Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lung Cancer Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Roche Diagnostics
• BioM?rieux
• Qiagen
• Advpharma
• AIT Austrian Institute of Technology
• Courtagen Life Sciences
• DiagnoCure
• BioMark Diagnostics
• Mayo Clinic
• HalioDx SAS

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Immunoassays
• Flow Cytometry
• Rapid Tests
• Molecular Assays
• Tissue Arrays
• Circulating Tumor Cells
• Pharmacodiagnostics
• Biomarkers
• Other

Market Segment by Applications, can be divided into

• Industrial
• Healthcare
• Other

Contents

1 LUNG CANCER DIAGNOSTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Lung Cancer Diagnostics
1.2 Classification of Lung Cancer Diagnostics by Types
  1.2.1 Global Lung Cancer Diagnostics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Lung Cancer Diagnostics Revenue Market Share by Types in 2017
  1.2.3 Immunoassays
  1.2.4 Flow Cytometry
  1.2.5 Rapid Tests
  1.2.6 Molecular Assays
  1.2.7 Tissue Arrays
  1.2.8 Circulating Tumor Cells
  1.2.9 Pharmacodiagnostics
  1.2.10 Biomarkers
  1.2.11 Other
1.3 Global Lung Cancer Diagnostics Market by Application
  1.3.1 Global Lung Cancer Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Industrial
  1.3.3 Healthcare
  1.3.4 Other
1.4 Global Lung Cancer Diagnostics Market by Regions
  1.4.1 Global Lung Cancer Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Lung Cancer Diagnostics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Lung Cancer Diagnostics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lung Cancer Diagnostics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Lung Cancer Diagnostics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lung Cancer Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Lung Cancer Diagnostics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Roche Diagnostics
  2.1.1 Business Overview
  2.1.2 Lung Cancer Diagnostics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 BioM?rieux
  2.2.1 Business Overview
  2.2.2 Lung Cancer Diagnostics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 BioM?rieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Qiagen
  2.3.1 Business Overview
  2.3.2 Lung Cancer Diagnostics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Advpharma
  2.4.1 Business Overview
  2.4.2 Lung Cancer Diagnostics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 AIT Austrian Institute of Technology
  2.5.1 Business Overview
  2.5.2 Lung Cancer Diagnostics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Courtagen Life Sciences
  2.6.1 Business Overview
  2.6.2 Lung Cancer Diagnostics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 DiagnoCure
  2.7.1 Business Overview
  2.7.2 Lung Cancer Diagnostics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioMark Diagnostics
  2.8.1 Business Overview
  2.8.2 Lung Cancer Diagnostics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Mayo Clinic
  2.9.1 Business Overview
  2.9.2 Lung Cancer Diagnostics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 HalioDx SAS
  2.10.1 Business Overview
  2.10.2 Lung Cancer Diagnostics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LUNG CANCER DIAGNOSTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Lung Cancer Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Lung Cancer Diagnostics Players Market Share
  3.2.2 Top 10 Lung Cancer Diagnostics Players Market Share
3.3 Market Competition Trend

4 GLOBAL LUNG CANCER DIAGNOSTICS MARKET SIZE BY REGIONS

4.1 Global Lung Cancer Diagnostics Revenue and Market Share by Regions
4.2 North America Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA LUNG CANCER DIAGNOSTICS REVENUE BY COUNTRIES

5.1 North America Lung Cancer Diagnostics Revenue by Countries (2013-2018)
5.2 USA Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

6 EUROPE LUNG CANCER DIAGNOSTICS REVENUE BY COUNTRIES

6.1 Europe Lung Cancer Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC LUNG CANCER DIAGNOSTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Lung Cancer Diagnostics Revenue by Countries (2013-2018)
7.2 China Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA LUNG CANCER DIAGNOSTICS REVENUE BY COUNTRIES

8.1 South America Lung Cancer Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE LUNG CANCER DIAGNOSTICS BY COUNTRIES

9.1 Middle East and Africa Lung Cancer Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)

10 GLOBAL LUNG CANCER DIAGNOSTICS MARKET SEGMENT BY TYPE

10.1 Global Lung Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Lung Cancer Diagnostics Market Forecast by Type (2018-2023)
10.3 Immunoassays Revenue Growth Rate (2013-2023)
10.4 Flow Cytometry Revenue Growth Rate (2013-2023)
10.5 Rapid Tests Revenue Growth Rate (2013-2023)
10.6 Molecular Assays Revenue Growth Rate (2013-2023)
10.7 Tissue Arrays Revenue Growth Rate (2013-2023)
10.8 Circulating Tumor Cells Revenue Growth Rate (2013-2023)
10.9 Pharmacodiagnostics Revenue Growth Rate (2013-2023)
10.10 Biomarkers Revenue Growth Rate (2013-2023)
10.11 Other Revenue Growth Rate (2013-2023)

11 GLOBAL LUNG CANCER DIAGNOSTICS MARKET SEGMENT BY APPLICATION

11.1 Global Lung Cancer Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Lung Cancer Diagnostics Market Forecast by Application (2018-2023)
11.3 Industrial Revenue Growth (2013-2018)
11.4 Healthcare Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)

12 GLOBAL LUNG CANCER DIAGNOSTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Lung Cancer Diagnostics Market Size Forecast (2018-2023)
12.2 Global Lung Cancer Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Lung Cancer Diagnostics Picture
Table Product Specifications of Lung Cancer Diagnostics
Table Global Lung Cancer Diagnostics and Revenue (Million USD) Market Split by Product Type
Figure Global Lung Cancer Diagnostics Revenue Market Share by Types in 2017
Figure Immunoassays Picture
Figure Flow Cytometry Picture
Figure Rapid Tests Picture
Figure Molecular Assays Picture
Figure Tissue Arrays Picture
Figure Circulating Tumor Cells Picture
Figure Pharmacodiagnostics Picture
Figure Biomarkers Picture
Figure Other Picture
Table Global Lung Cancer Diagnostics Revenue (Million USD) by Application (2013-2023)
Figure Lung Cancer Diagnostics Revenue Market Share by Applications in 2017
Figure Industrial Picture
Figure Healthcare Picture
Figure Other Picture
Table Global Market Lung Cancer Diagnostics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche Diagnostics Lung Cancer Diagnostics Type and Applications
Table Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table BioM?rieux Basic Information, Manufacturing Base and Competitors
Table BioM?rieux Lung Cancer Diagnostics Type and Applications
Table BioM?rieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Lung Cancer Diagnostics Type and Applications
Table Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Advpharma Basic Information, Manufacturing Base and Competitors
Table Advpharma Lung Cancer Diagnostics Type and Applications
Table Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table AIT Austrian Institute of Technology Basic Information, Manufacturing Base and Competitors
Table AIT Austrian Institute of Technology Lung Cancer Diagnostics Type and Applications
Table AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Courtagen Life Sciences Basic Information, Manufacturing Base and Competitors
Table Courtagen Life Sciences Lung Cancer Diagnostics Type and Applications
Table Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table DiagnoCure Basic Information, Manufacturing Base and Competitors
Table DiagnoCure Lung Cancer Diagnostics Type and Applications
Table DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table BioMark Diagnostics Basic Information, Manufacturing Base and Competitors
Table BioMark Diagnostics Lung Cancer Diagnostics Type and Applications
Table BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Mayo Clinic Basic Information, Manufacturing Base and Competitors
Table Mayo Clinic Lung Cancer Diagnostics Type and Applications
Table Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table HalioDx SAS Basic Information, Manufacturing Base and Competitors
Table HalioDx SAS Lung Cancer Diagnostics Type and Applications
Table HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Lung Cancer Diagnostics Revenue (Million USD) by Players (2013-2018)
Table Global Lung Cancer Diagnostics Revenue Share by Players (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Share by Players in 2016
Figure Global Lung Cancer Diagnostics Revenue Share by Players in 2017
Figure Global Top 5 Players Lung Cancer Diagnostics Revenue Market Share in 2017
Figure Global Top 10 Players Lung Cancer Diagnostics Revenue Market Share in 2017
Figure Global Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Lung Cancer Diagnostics Revenue (Million USD) by Regions (2013-2018)
Table Global Lung Cancer Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Market Share by Regions (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Market Share by Regions in 2017
Figure North America Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Europe Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure South America Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table North America Lung Cancer Diagnostics Revenue by Countries (2013-2018)
Table North America Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Lung Cancer Diagnostics Revenue Market Share by Countries in 2017
Figure USA Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Canada Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Mexico Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table Europe Lung Cancer Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Europe Lung Cancer Diagnostics Revenue Market Share by Countries in 2017
Figure Germany Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure UK Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure France Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Russia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Italy Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Lung Cancer Diagnostics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Lung Cancer Diagnostics Revenue Market Share by Countries in 2017
Figure China Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Japan Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Korea Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure India Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table South America Lung Cancer Diagnostics Revenue by Countries (2013-2018)
Table South America Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Lung Cancer Diagnostics Revenue Market Share by Countries in 2017
Figure Brazil Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Argentina Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Colombia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Lung Cancer Diagnostics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lung Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lung Cancer Diagnostics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure UAE Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Egypt Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure Nigeria Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Figure South Africa Lung Cancer Diagnostics Revenue and Growth Rate (2013-2018)
Table Global Lung Cancer Diagnostics Revenue (Million USD) by Type (2013-2018)
Table Global Lung Cancer Diagnostics Revenue Share by Type (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Share by Type (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Share by Type in 2017
Table Global Lung Cancer Diagnostics Revenue Forecast by Type (2018-2023)
Figure Global Lung Cancer Diagnostics Market Share Forecast by Type (2018-2023)
Figure Global Immunoassays Revenue Growth Rate (2013-2018)
Figure Global Flow Cytometry Revenue Growth Rate (2013-2018)
Figure Global Rapid Tests Revenue Growth Rate (2013-2018)
Figure Global Molecular Assays Revenue Growth Rate (2013-2018)
Figure Global Tissue Arrays Revenue Growth Rate (2013-2018)
Figure Global Circulating Tumor Cells Revenue Growth Rate (2013-2018)
Figure Global Pharmacodiagnostics Revenue Growth Rate (2013-2018)
Figure Global Biomarkers Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Lung Cancer Diagnostics Revenue by Application (2013-2018)
Table Global Lung Cancer Diagnostics Revenue Share by Application (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Share by Application (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue Share by Application in 2017
Table Global Lung Cancer Diagnostics Revenue Forecast by Application (2018-2023)
Figure Global Lung Cancer Diagnostics Market Share Forecast by Application (2018-2023)
Figure Global Industrial Revenue Growth Rate (2013-2018)
Figure Global Healthcare Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Lung Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Lung Cancer Diagnostics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Lung Cancer Diagnostics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
Figure Europe Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
Figure South America Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Lung Cancer Diagnostics Revenue Market Forecast (2018-2023)